$38.49
1.022.72%
In chiusura: -
$38.35
-0.14-0.36%
After hour: 4:00 PM EDT
Comments
Loading...
Stime degli utili, EPS e fatturato
Kiniksa Pharmaceuticals segnala gli utili su base trimestrale. Questi report sugli utili trimestrali offrono agli investitori uno sguardo ai risultati finanziari di un'azienda per un periodo di 3 mesi. I report sugli utili includono quasi sempre i risultati EPS e i ricavi.
Data degli utili
ott 28
Stima EPS
$0.340
Stima dei ricavi trimestrali
$166.59M
Ricavi annuali
(a partire da giu 30)
(a partire da giu 30)
$529.33M
Analizza lo storico degli utili di Kiniksa Pharmaceuticals utilizzando ordinamenti e filtri avanzati.
Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
KNSA | Kiniksa Pharmaceuticals | -$0.18 | $0.34 | — | — | $112.21M | $166.59M | — | — | 10/28/2025 | |
KNSA | Kiniksa Pharmaceuticals | -$0.06 | $0.21 | $0.23 | 9.52% | $108.63M | $145.24M | $156.80M | 7.95% | 07/29/2025 | |
KNSA | Kiniksa Pharmaceuticals | -$0.25 | $0.28 | $0.11 | -60.71% | $79.86M | $131.71M | $137.78M | 4.61% | 04/29/2025 | |
KNSA | Kiniksa Pharmaceuticals | $0.35 | $0.13 | -$0.12 | -192.31% | $83.39M | $123.38M | $122.54M | -0.68% | 02/25/2025 | |
KNSA | Kiniksa Pharmaceuticals | -$0.20 | $0.03 | -$0.18 | -700.00% | $67.05M | $111.52M | $112.21M | 0.62% | 10/29/2024 | |
KNSA | Kiniksa Pharmaceuticals | -$0.02 | -$0.07 | -$0.06 | 14.29% | $71.47M | $92.31M | $108.63M | 17.68% | 07/23/2024 | |
KNSA | Kiniksa Pharmaceuticals | -$0.18 | -$0.16 | -$0.25 | -56.25% | $48.34M | $78.46M | $79.86M | 1.78% | 04/23/2024 | |
KNSA | Kiniksa Pharmaceuticals | $0.06 | -$0.14 | $0.35 | 350.00% | $61.88M | $72.02M | $83.39M | 15.79% | 02/28/2024 | |
KNSA | Kiniksa Pharmaceuticals | $3.18 | -$0.17 | -$0.20 | -17.65% | $99.14M | $64.45M | $67.05M | 4.03% | 10/31/2023 | |
KNSA | Kiniksa Pharmaceuticals | -$0.29 | -$0.17 | -$0.02 | 88.24% | $26.97M | $52.20M | $71.47M | 36.92% | 07/25/2023 | |
KNSA | Kiniksa Pharmaceuticals | -$0.36 | -$0.21 | -$0.18 | 14.29% | $32.19M | $46.58M | $48.34M | 3.79% | 05/02/2023 | |
KNSA | Kiniksa Pharmaceuticals | -$0.53 | -$0.23 | $0.06 | 126.09% | $18.75M | $45.11M | $61.88M | 37.18% | 02/28/2023 | |
KNSA | Kiniksa Pharmaceuticals | -$0.44 | $0.50 | $3.18 | 536.00% | $12.10M | $74.39M | $99.14M | 33.26% | 11/01/2022 | |
KNSA | Kiniksa Pharmaceuticals | -$0.61 | -$0.44 | -$0.29 | 34.09% | $7.70M | $28.55M | $26.97M | -5.53% | 08/03/2022 | |
KNSA | Kiniksa Pharmaceuticals | -$0.72 | -$0.41 | -$0.36 | 12.20% | $0.00 | $22.77M | $32.19M | 41.37% | 05/03/2022 | |
KNSA | Kiniksa Pharmaceuticals | -$0.79 | -$0.42 | -$0.53 | -26.19% | $0.00 | $20.72M | $18.75M | -9.53% | 02/22/2022 | |
KNSA | Kiniksa Pharmaceuticals | -$0.66 | -$0.65 | -$0.44 | 32.31% | $0.00 | $10.18M | $12.10M | 18.81% | 11/01/2021 | |
KNSA | Kiniksa Pharmaceuticals | -$0.65 | -$0.79 | -$0.61 | 22.78% | $0.00 | $3.97M | $7.70M | 94.06% | 08/03/2021 | |
KNSA | Kiniksa Pharmaceuticals | -$0.48 | -$0.80 | -$0.72 | 10.00% | $0.00 | $3.72M | $0.00 | -100.00% | 05/04/2021 | |
KNSA | Kiniksa Pharmaceuticals | -$0.58 | — | -$0.79 | — | $0.00 | — | $0.00 | — | 02/23/2021 | |
KNSA | Kiniksa Pharmaceuticals | -$0.49 | — | -$0.66 | — | $0.00 | — | $0.00 | — | 11/05/2020 |
Kiniksa Pharmaceuticals (KNSA) Guadagno per azione
Importo a sorpresa sugli utili trimestrali
| Trimestre fiscale | Data segnalata | EPS effettivo | EPS stimato | Sorpresa% |
|---|---|---|---|---|
| Q2 | 2025-07-29 | $0.23 | $0.21 | 9.52 % |
| Q1 | 2025-04-29 | $0.11 | $0.28 | -60.7 % |
| Q4 | 2025-02-25 | $-0.12 | $0.13 | -192.3 % |
| Q3 | 2024-10-29 | $-0.18 | $0.03 | -700.0 % |
Kiniksa Pharmaceuticals (KNSA) Entrate
Importo sorpresa sulle entrate trimestrali
| Trimestre fiscale | Data segnalata | Entrate effettive | Entrate stimate | Sorpresa% |
|---|---|---|---|---|
| Q2 | 2025-07-29 | $156.80M | $145.24M | 7.95 % |
| Q1 | 2025-04-29 | $137.79M | $131.71M | 4.61 % |
| Q4 | 2025-02-25 | $122.54M | $123.38M | -0.68 % |
| Q3 | 2024-10-29 | $112.21M | $111.52M | 0.62 % |
FAQ
Quando Kiniksa Pharmaceuticals (NASDAQ:KNSA) riporterà gli utili?
Si prevede che Kiniksa Pharmaceuticals (KNSA) fornisca risultati il ottobre 28, 2025. Gli ultimi risultati sono stati pubblicati il luglio 29, 2025 per il Q2.
Quali sono stati gli ultimi utili per azione (EPS) di Kiniksa Pharmaceuticals (NASDAQ:KNSA)?
L'EPS effettivo era $0.23, che superato la stima di $0.21.
Quali sono state le entrate di Kiniksa Pharmaceuticals (NASDAQ:KNSA)?
Le entrate effettive sono state $156.8M, che superato la stima di $145.2M.
Sfoglia stime sugli utili, EPS e ricavi su tutte le azioni.